NanoViricides announced that it has filed an Orphan Drug Application to the FDA for DengueCide, a drug candidate for the treatment of dengue and dengue hemorrhagic fever. DengueCide is a nanoviricide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results